According to a new study of more than 5,000 people, late 30s might be a critical time to start drug therapy to halt the progression of multiple sclerosis (MS). Researchers told the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2019 that until their mid to late 30s, some people with the condition’s bodies compensate for central nervous system damage, but after the age of 40, the risk for disability rises. ‘The age between 37 and 40 seems critical with regard to the compensation of the central nervous system damage caused by MS,’ Viktor von Wyl, PhD, of the Department of Epidemiology, Institute for Epidemiology, Biostatistics and Prevention at the University of Zurich told the Congress.
The researchers said the findings carry implications for future research and for the timing of people beginning disease modifying therapy (DMT).
Source MS-UK 06/11/2019